The Chinese gene-editing experiment was an outrage. The scientific community shares blame.
By J. Benjamin Hurlbut, Sheila Jasanoff and Krishanu Saha,
The Washington Post
| 11. 29. 2018
This is the experiment that was not supposed to happen.
A Chinese scientist claimed this week that he had produced the first genetically engineered babies — twin girls who have been “edited” to be resistant to HIV. He and his collaborators, who apparently include a professor at Rice University in Houston, allegedly applied the genome editing tool known as CRISPR to embryos produced through in vitro fertilization to modify a gene called CCR5. The purpose of the edit was to prevent future HIV infection, a move akin to a genetic vaccination.
Three years ago, scientists, social scientists and ethicists gathered in Washington at the National Academy of Sciences for the first international summit on human gene editing, to discuss scientific, social and ethical issues surrounding human applications of this powerful new tool. One result of the meeting was a call for a voluntary international moratorium on reproductive applications of genome editing until there was “broad societal consensus” about when making such heritable modifications is ethically acceptable.
Nothing remotely like a consensus has been reached, yet the research races ahead. Numerous...
Related Articles
By Carl Zimmer, The New York Times | 10.20.2026
For the first time, scientists say they have used viruses designed by artificial intelligence to treat a human patient.
Researchers announced on Tuesday that they had administered the virus, known as a phage, to a patient suffering from a deadly...
By Noah Fromson, HealthLab | 10.19.2026
Gene therapy is no longer the future of medicine — it’s reality. Treatments that replace, silence or edit genes are already changing clinical care.
There are more than 6,000 rare genetic disorders but only a fraction currently have treatable targets...
By Roxanne Khamsi, The Atlantic | 10.16.2026
In recent months, news came out about several distressing cases that have underscored the risks of gene therapy, which delivers DNA to a patient’s cells to treat disease. All of these cases have one thing in common that’s not apparent...
By Rebecca Roberts, The Scientist | 10.11.2026
Heritable genome editing in human embryos is once again under intense scrutiny after the publication of an opinion piece in Trends in Genetics at the end of last month.1 In the paper, Cathy Tie, the founder and chief...